Standard BioTools Inc. Inventory, LIFO Reserve, Period Charge
Standard BioTools Inc. (LAB) reported Inventory, LIFO Reserve, Period Charge of $1.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:InventoryLIFOReservePeriodCharge · last filed 2026-08-05
- Standard BioTools Inc. inventory, lifo reserve, period charge for the quarter ending 2026-06-30 was $1.07M, a 97.06% increase year-over-year.
- Standard BioTools Inc. inventory, lifo reserve, period charge for the quarter ending 2026-03-31 was $696.00K, a 14.60% decline year-over-year.
- Standard BioTools Inc. inventory, lifo reserve, period charge for the quarter ending 2025-12-31 was $1.49M, a 180.11% increase year-over-year.
- Standard BioTools Inc. inventory, lifo reserve, period charge for the quarter ending 2025-09-30 was $615.00K, a 515.00% increase year-over-year.
- Standard BioTools Inc. inventory, lifo reserve, period charge for fiscal 2025 was $3.47M, a 37.40% increase from fiscal 2024.
- Standard BioTools Inc. inventory, lifo reserve, period charge for fiscal 2024 was $2.52M, a 68.72% increase from fiscal 2023.
- Standard BioTools Inc. inventory, lifo reserve, period charge for fiscal 2023 was $1.50M, a 81.00% decline from fiscal 2022.
- Standard BioTools Inc. inventory, lifo reserve, period charge for fiscal 2022 was $7.87M, a 243.39% increase from fiscal 2021.
| Period end | Inventory, LIFO Reserve, Period Charge 3 month | Inventory, LIFO Reserve, Period Charge 6 month | Inventory, LIFO Reserve, Period Charge 9 month | Inventory, LIFO Reserve, Period Charge 12 month | Inventory, LIFO Reserve, Period Charge 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.77M 10-Q · filed 2026-08-05 | $3.26M derived: sum of 3 quarters · filed 2026-08-05 | $3.88M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $696.00K 10-Q · filed 2026-05-06 | $2.19M derived: sum of 2 quarters · filed 2026-05-06 | $2.80M derived: sum of 3 quarters · filed 2026-05-06 | $3.35M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.11M derived: sum of 2 quarters · filed 2026-03-16 | $2.65M derived: sum of 3 quarters · filed 2026-08-05 | $3.47M 10-K · filed 2026-03-16 | |
| 2025-09-30 | $615.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.16M derived: sum of 2 quarters · filed 2026-08-05 | $1.98M 10-Q · filed 2025-11-04 | $2.51M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $545.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.36M 10-Q · filed 2026-08-05 | $1.89M derived: sum of 3 quarters · filed 2026-08-05 | $1.99M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $815.00K 10-Q · filed 2026-05-06 | $1.35M derived: sum of 2 quarters · filed 2026-05-06 | $1.45M derived: sum of 3 quarters · filed 2026-05-06 | $2.65M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $533.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $633.00K derived: sum of 2 quarters · filed 2026-03-16 | $1.83M derived: sum of 3 quarters · filed 2026-03-16 | $2.52M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-06 | $1.30M derived: sum of 2 quarters · filed 2024-11-06 | $1.99M 10-Q · filed 2025-11-04 | $2.49M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-06-30 | $1.20M 10-Q · filed 2024-08-06 | $1.87M 10-Q · filed 2025-08-15 | $2.39M derived: sum of 3 quarters · filed 2026-03-16 | $2.79M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-03-31 | $655.00K 10-Q · filed 2025-05-06 | $1.19M derived: sum of 2 quarters · filed 2026-03-16 | $1.59M derived: sum of 3 quarters · filed 2026-03-16 | $1.79M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2023-12-31 | $533.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $933.00K derived: sum of 2 quarters · filed 2026-03-16 | $1.13M derived: sum of 3 quarters · filed 2026-03-16 | $1.50M 10-K · filed 2026-03-16 | |
| 2023-09-30 | $400.00K 10-Q · filed 2024-11-06 | $600.00K derived: sum of 2 quarters · filed 2024-11-06 | $963.00K 10-Q · filed 2024-11-06 | $1.58M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | $200.00K 10-Q · filed 2024-08-06 | $572.00K 10-Q · filed 2024-08-06 | $1.19M derived: sum of 3 quarters · filed 2025-03-11 | $3.83M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | $350.00K 10-Q · filed 2024-05-09 | $985.00K derived: sum of 2 quarters · filed 2025-03-11 | $3.63M derived: sum of 3 quarters · filed 2025-03-11 | $7.37M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2022-12-31 | $635.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $3.28M derived: sum of 2 quarters · filed 2025-03-11 | $7.02M derived: sum of 3 quarters · filed 2025-03-11 | $7.87M 10-K · filed 2025-03-11 | |
| 2022-09-30 | $2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $6.39M derived: sum of 2 quarters · filed 2023-11-07 | $7.24M 10-Q · filed 2023-11-07 | $7.99M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $4.60M 10-Q · filed 2023-08-08 | $5.35M derived: sum of 3 quarters · filed 2023-08-08 | $5.64M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $851.00K 10-Q · filed 2023-05-09 | $1.60M derived: sum of 2 quarters · filed 2023-05-09 | $1.90M derived: sum of 3 quarters · filed 2023-05-09 | $2.83M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $754.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.04M derived: sum of 2 quarters · filed 2023-03-14 | $1.98M derived: sum of 3 quarters · filed 2023-03-14 | $2.29M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.22M derived: sum of 2 quarters · filed 2022-11-09 | $1.54M 10-Q · filed 2022-11-09 | $2.47M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $933.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.25M 10-Q · filed 2022-08-09 | $2.18M derived: sum of 3 quarters · filed 2022-08-09 | $2.56M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $315.00K 10-Q · filed 2022-05-09 | $1.25M derived: sum of 2 quarters · filed 2022-05-09 | $1.62M derived: sum of 3 quarters · filed 2022-05-09 | $1.73M derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | $934.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.31M derived: sum of 2 quarters · filed 2022-03-08 | $1.42M derived: sum of 3 quarters · filed 2022-03-08 | $1.61M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $374.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $485.00K derived: sum of 2 quarters · filed 2021-11-09 | $680.00K 10-Q · filed 2021-11-09 | $1.13M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-06-30 | $111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $306.00K 10-Q · filed 2021-08-06 | $757.00K derived: sum of 3 quarters · filed 2022-03-08 | $1.56M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-03-31 | $195.00K 10-Q · filed 2021-05-07 | $646.00K derived: sum of 2 quarters · filed 2022-03-08 | $1.45M derived: sum of 3 quarters · filed 2022-03-08 | $1.87M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2019-12-31 | $451.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.25M derived: sum of 2 quarters · filed 2022-03-08 | $1.67M derived: sum of 3 quarters · filed 2022-03-08 | $1.81M 10-K · filed 2022-03-08 | $1.45M 10-K · filed 2020-02-27 |
| 2019-09-30 | $801.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.22M derived: sum of 2 quarters · filed 2020-11-09 | $1.36M 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $420.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $555.00K 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | $135.00K 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | $1.09M 10-K · filed 2021-02-25 | $1.03M 10-K · filed 2020-02-27 | |||
| 2017-12-31 | $434.00K 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |